In the literature, beside its proteasome inhibition function, which is nonspecific to all eukaryotic cells, BZM also specifically inhibits the NF-κB pathway, which is important for the production of essential growth factors such as interleukin-6 (IL-6) in myeloma cells, is discussed as a specific effect [3,4,5]. Here, IL6 is linked to plasma cell myeloma.